Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas.
Kinker GS, Vitiello GAF, Diniz AB, Cabral-Piccin MP, Pereira PHB, Carvalho MLR, Ferreira WAS, Chaves AS, Rondinelli A, Gusmão AF, Defelicibus A, Dos Santos GO, Nunes WA, Claro LCL, Bernardo TM, Nishio RT, Pacheco AM, Laus AC, Arantes LMRB, Fleck JL, de Jesus VHF, de Moricz A, Weinlich R, Coimbra FJF, de Lima VCC, Medina TDS. Kinker GS, et al. Among authors: de lima vcc. Gut. 2023 Oct;72(10):1927-1941. doi: 10.1136/gutjnl-2022-328697. Epub 2023 May 25. Gut. 2023. PMID: 37230755
The roles of PTEN, cMET, and p16 in resistance to cetuximab in head and neck squamous cell carcinoma.
da Costa AABA, Costa FD, Araújo DV, Camandaroba MPG, de Jesus VHF, Oliveira A, Alves ACF, Stecca C, Machado L, de Oliveira ACF, de Oliveira TB, Nicolau UR, de Lima VCC. da Costa AABA, et al. Among authors: de lima vcc, de oliveira acf, de jesus vhf, de oliveira tb. Med Oncol. 2018 Nov 26;36(1):8. doi: 10.1007/s12032-018-1234-0. Med Oncol. 2018. PMID: 30478503
An integrative microenvironment approach for follicular lymphoma: roles of inflammatory cell subsets and immune-response polymorphisms on disease clinical course.
Assis-Mendonça GR, Fattori A, Rocha RM, Lourenço GJ, Delamain MT, Nonogaki S, de Lima VCC, Colleoni GWB, de Souza CA, Soares FA, Lima CSP, Vassallo J. Assis-Mendonça GR, et al. Among authors: de lima vcc, lima csp, de souza ca. Oncotarget. 2020 Aug 18;11(33):3153-3173. doi: 10.18632/oncotarget.27698. eCollection 2020 Aug 18. Oncotarget. 2020. PMID: 32913559 Free PMC article.
HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer.
de Moura Leite L, Cesca MG, Tavares MC, Santana DM, Saldanha EF, Guimarães PT, Sá DDS, Simões MFE, Viana RL, Rocha FG, Loose SK, Silva SF, Pirolli R, Fogassa CAZ, Mattos BRS, Campos FAB, Sanches SM, de Lima VCC, Pondé NF. de Moura Leite L, et al. Among authors: de lima vcc. Breast Cancer Res Treat. 2021 Nov;190(1):155-163. doi: 10.1007/s10549-021-06365-7. Epub 2021 Aug 18. Breast Cancer Res Treat. 2021. PMID: 34409551
Single nucleotide variants in immune-response genes and the tumor microenvironment composition predict progression of mantle cell lymphoma.
Assis-Mendonça GR, Fattori A, Rocha RM, Lourenço GJ, Delamain MT, Nonogaki S, de Lima VCC, Colleoni GWB, de Souza CA, Soares FA, Lima CSP, Vassallo J. Assis-Mendonça GR, et al. Among authors: de lima vcc, lima csp, de souza ca. BMC Cancer. 2021 Mar 1;21(1):209. doi: 10.1186/s12885-021-07891-9. BMC Cancer. 2021. PMID: 33648463 Free PMC article.
BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation.
Brianese RC, Nakamura KDM, Almeida FGDSR, Ramalho RF, Barros BDF, Ferreira ENE, Formiga MNDC, de Andrade VP, de Lima VCC, Carraro DM. Brianese RC, et al. Among authors: de lima vcc, de andrade vp. Breast Cancer Res Treat. 2018 Feb;167(3):803-814. doi: 10.1007/s10549-017-4552-6. Epub 2017 Nov 7. Breast Cancer Res Treat. 2018. PMID: 29116469
33 results